-
Before SARS-CoV-2, Aegis Sciences Corporation was a small, well-established lab with a specific niche. Founded in 1990, the Nashville-based company focused on anti-doping testing and medication compliance.
-
The 2022–23 “tripledemic” season—in which influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) all surged at the same time—was especially bad for Arizona, says Efrem Lim, an Arizona State University (ASU) virologist with the Center for Fundamental and Applied Microbiomics
-
New research published in The Lancet reinforces the idea that handwashing outside of pandemic times is vital in order to reduce the burden of common colds and flu in low- and middle-income countries.
-
Initial Deployment Across South Africa to Support Self-testers with Medical Diagnostech’s COVID-19 Antigen Test
-
Hologic “Making a World of Difference” Through Global Sustainability Impact
-
In a study in Virus Evolution, our Pandemic Defense Coalition partner Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation and Abbott’s Virus Hunters looked at lineages of SARS-CoV-2 in Senegal over six months.
-
In 2021, Quest labs continued to work with the Centers for Disease Control and Prevention (CDC) on genomic sequencing of SARS-CoV-2, the virus that causes COVID-19.
-
Gilead scientists had planned for a moment like this through years of research. When coronaviruses with pandemic potential, like SARS and MERS, emerged in the early 2000s, Gilead began searching for potential new antivirals.
-
Provides Additional Performance Testing Update
-
-Company to Provide Additional Testing Results while Expanding Global Footprint-
-
Achieves Monthly Record Issued Request for Quotations in December 2021
Provides Key Strategic Initiatives for 2022
-
Unit Shipments Increase with Continued Expansion of BioCloud Footprint
-
Kontrol Technologies to Deliver BioCloud Software Update adds New Health Care Distribution Partner and Advances Replacement Cartridge Longevity
-
Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities
-
Positive In-field Performance Drives Increased Demand for BioCloud Data and Analytics
-
-Partnership with Kontrol's BioCloud® Technology to Provide Real-Time Detection of Airborne Pathogens to Create Safer Spaces-
-
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will donate 100,000 vials of Veklury® (remdesivir) to help address the recent surge of COVID-19 cases in Indonesia and 3,000 vials of Veklury to help patients hospitalized with COVID-19 in Armenia. “As cases of COVID-19 surge again around the world, and the pandemic continues to affect the lives of so many, we remain focused on ensuring that our medicines can reach patients that need them,” said Johanna Mercier, Chief Commerci
-
-
Expanded agreement brings the total number of COVID-19 vaccine doses to be supplied to the U.S. government for donation to one billion
-
Effort contributes to companies’ pledge to deliver two billion COVID-19 vaccine doses to low- and middle-income countries by the end of 2022
-
Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to help expand SARS-CoV-2 sequencing capabilities in the region and support the broader genomic surveillance effort across India.
-
The COVID-19 pandemic is a hands-on workshop in how genetic information can help us more quickly control a pandemic. Relying on the SARS-CoV-2 code, researchers at academic labs were ready to develop a diagnostic test for the virus within weeks.
-
Illumina's NextSeq 1000/2000 sequencing systems are based on a technology that leverages light to decipher the genome. The instruments are used, among other things, to determine the genetic profile of the SARS-CoV-2 virus and its variants.
-
SOURCE: Black Veatch DESCRIPTION:SAN DIEGO, Calif., July 21, 2021 /3BL Media/ – With indoor air quality more essential than ever with the infectious COVID-19 still active worldwide, eradicating the virus while it’s airborne is crucial to mitigating its transmission. Energy Cloud, a clean-tech company specializing in healthy buildings and energy efficient environments has a solution: Hummingbird™ EQ, an air purification system that captures and deactivates airborne COVID-19 virus. Hummingbird™ EQ
-
Promega Corporation sets 2030 sustainability targets as part of the biotech company's newly launched 2021 Corporate Responsibility Report.
-
-
Zoetis Foundation commits $35 million over 5 years to advance opportunities for veterinarians and farmers
-
Donated over $6 million in community support during 2020 with nearly 10% of that supporting COVID-19 relief efforts
-
On track to 100% renewable energy and RE100 commitment with 8.8% renewable electricity sourced
-
CR Forum Bestows Additional Honors to Outstanding Clinical Research Organizations for Groundbreaking Clinical and Translational Research Advancements with 2021 Top 10 Clinical Research Achievement Awards
-
Long Island Jewish Medical Center nurse Sandra Lindsay’s historic first Pfizer-BioNTech vaccine will now be part of National Museum of American History Collections
-
In response to a fractured global response to COVID-19 as humanity’s greatest existential threat, AIDS Healthcare Foundation calls for what amounts to a declaration of war on the novel coronavirus and future pandemics
-
15 years ago, Lidia Morawska from Queensland University gave a presentation on strategies to prevent the global spread of an invisible, but deadly enemy - SARS.
-
Since the beginning of the COVID-19 pandemic, our High Performance Buildings Group has conducted research into the role that mechanical, electrical, and plumbing (MEP) design can play in mitigating the spread of the SARS-CoV-2 in the built environment.
-
FDA Authorizes Ecolab's Bioquell Technology System for N95 Respirator Decontamination Fri, 12/18/2020 - 09:30 Subheader Ecolab’s decontamination technology enables respirator reuse by healthcare personnel to help address shortages Type of Content Press Release Layout Standard Format Body ST. PAUL, Minn. – December 18, 2020 /3BL Media/ – Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has received Emergency
-
Clinical Research Program Underway To Validate Potential of Oral Health Products to Slow Spread of the Virus
-
Ecolab Receives First EPA Approval for Biofilm Disinfection in Drains Thu, 11/19/2020 - 09:10 Type of Content Press Release Layout Standard Format Body ST. PAUL, Minn., November 19, 2020 /3BL Media/ - Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, is the first to receive EPA product approval for disinfection of biofilms[i] in wastewater drains for its Virasept™ product – an important part of a comprehensive environmental hygiene program designed
-
Grants Will Be Administered through the MECTIZAN® Donation Program and Will Support Precautionary Measures Required to Prevent the Spread of SARS-CoV-2 During Mass Drug Administration Programs for These Two Diseases
-
Public Health Awareness Campaign to Promote Access to Health Among Underserved Communities, and Help Reduce the Spread of COVID-19 in Hot Spots
-
3M (@3M) and Discovery Education (@DiscoveryEd) have named 14-year-old Anika Chebrolu from Frisco, Tex. the winner of the 2020 3M Young Scientist Challenge (#YoungScientist), the nation’s premier middle school science competition.
-
21 winning teams selected to receive funding for innovative solutions to most pressing issues caused by pandemic
-
Nonprofit Will Enable Access to Proprietary SHERLOCK™ CRISPR-based Technology to Support Third-party Development of COVID-19 Diagnostic Tests
Proceeds to Support Racial and Gender Diversity in STEM
-
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19.
-
Facedrive Inc. (“Facedrive”) (TSXV: FD), a “people-and-planet first” business, is pleased to announce “TraceSCAN”, the COVID-19 contact tracing platform which includes an application, wearables and artificial intelligence technology that helps to mitigate the spread of COVID-19 and predict future outbreaks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200528005281/en/ TraceSCAN, a joint initiative by Facedrive Health and the Univers
-
In this 30-minute webinar, Tetra Tech’s emergency management experts focused on practical considerations when planning and conducting disinfection activities aimed at limiting the transmission of novel coronavirus (SARS-CoV-2) in key environments. As this is an evolving response and recommendations may change over time, it is important to convey the right information.
-
Intel's Pandemic Response Team began as an informal group of executives who coordinated efforts to protect employees & customers while supporting health agencies in the fight against SARS, but it soon evolved into a standing team within the company.
-
Our newly established testing laboratory in Berlin which supports the fight against the Corona virus is already running: In the lab, our employees – more than 140 have volunteered – are able to conduct up to 1,000 additional SARS-CoV-2 tests per day.
-
As SARS-CoV-2 moves fast through our global population, the pharmaceutical industry faces tremendous pressure to move even faster. CRB has a list of tactics to help your organization speed up.
-
Devices will be used to ensure temperature tolerances are maintained during transport and storage of COVID-19 specimens
-
Wasted Natural Gas To Power The Fight Against COVID-19
-
Ebola, Zika, SARS and the return of avian flu to the headlines recently are reminders that the threat of a new epidemic is never far away. With increased air travel and populations on the move, it doesn’t take long for a virus to spread between countries and jump across continents, with potentially catastrophic results.\r\r